Artivion, Inc. (AORT) vs Bioventus Inc. (BVS)
Artivion, Inc. and Bioventus Inc. are both Medical Devices companies. Artivion, Inc. and Bioventus Inc. are of similar size ($1.1B and $1.1B). Artivion, Inc. has negative trailing earnings, so its P/E is not meaningful; Bioventus Inc. trades at 17.0×. Artivion, Inc. grew revenue faster over the last twelve months: 16.4% against 3.14%. Bioventus Inc. has the higher net margin (9.36% vs −0.67%) and the higher return on invested capital (7.34% vs 1.76%). Across the 20 metrics below, Bioventus Inc. leads on 15 and Artivion, Inc. on 5.
Valuation
Profitability
| Metric | AORT | BVS | Medical Devices median |
|---|---|---|---|
| Gross margin | 64.37% | 68.65% | 56.01% |
| Operating margin | 4.38% | 10.02% | (15.03%) |
| Net margin | (0.67%) | 9.36% | (20.40%) |
| Free cash flow margin | (1.94%) | 16.20% | (7.24%) |
| Return on equity | (0.73%) | 22.75% | (15.32%) |
| Return on assets | (0.33%) | 7.89% | (19.72%) |
| Return on invested capital | 1.76% | 7.34% | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack